John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$275M |
| 2 |
Netflix
NFLX
|
+$254M |
| 3 |
Microsoft
MSFT
|
+$242M |
| 4 |
Qualcomm
QCOM
|
+$236M |
| 5 |
Starbucks
SBUX
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$236M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$221M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$191M |
| 4 |
McDonald's
MCD
|
+$183M |
| 5 |
Union Pacific
UNP
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.08% |
| 2 | Healthcare | 12.88% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 10.88% |
| 5 | Industrials | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLI
2776
Standard Lithium
SLI
$600M
| $49.2K | ﹤0.01% |
+17,378
| New | +$66.7K |
|
|
SUP
2777
DELISTED
Superior Industries International
SUP
| $48.9K | ﹤0.01% |
16,100
| – | – |
|
|
CTV
2778
DELISTED
Innovid Corp.
CTV
| $48.7K | ﹤0.01% |
38,026
+20,272
| +114% | +$23.7K |
|
2779
Twin Vee PowerCats
VEEE
$6.05M
| $47.9K | ﹤0.01% |
95
-19
| -17% | -$13.3K |
|
2780
SmartRent
SMRT
$268M
| $47.2K | ﹤0.01% |
+18,086
| New | +$61.5K |
|
2781
Chanson International
CHSN
$2.55M
| $47K | ﹤0.01% |
+2
| New | +$34.6K |
|
|
EPIX
2782
DELISTED
ESSA Pharma
EPIX
| $46.9K | ﹤0.01% |
15,188
-6,758
| -31% | -$19.5K |
|
|
ADAP
2783
DELISTED
Adaptimmune Therapeutics
ADAP
| $46.9K | ﹤0.01% |
60,074
-50,100
| -45% | -$42K |
|
2784
Jasper Therapeutics
JSPR
$24M
| $46.3K | ﹤0.01% |
+6,609
| New | +$80.7K |
|
|
MTBL
2785
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
| $46.2K | ﹤0.01% |
46,244
-1,500
| -3% | -$1.87K |
|
2786
Protara Therapeutics
TARA
$229M
| $45.7K | ﹤0.01% |
27,345
-7,400
| -21% | -$17K |
|
|
BLPH
2787
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $45.3K | ﹤0.01% |
113,911
+10,124
| +10% | +$4.99K |
|
|
AHG
2788
Akso Health Group
AHG
$808M
| $45.2K | ﹤0.01% |
43,638
-58,293
| -57% | -$33.4K |
|
|
GAN
2789
DELISTED
GAN Ltd
GAN
| $44.7K | ﹤0.01% |
38,500
-95,654
| -71% | -$150K |
|
2790
HCW Biologics
HCWB
$4.24M
| $43.4K | ﹤0.01% |
95
-16
| -14% | -$7.91K |
|
2791
Alaunos Therapeutics
TCRT
$4.37M
| $40.8K | ﹤0.01% |
2,061
-717
| -26% | -$30.9K |
|
2792
Prelude Therapeutics
PRLD
$516M
| $39.6K | ﹤0.01% |
12,813
-26,477
| -67% | -$99.4K |
|
2793
Singularity Future Technology
SGLY
$2.27M
| $38.3K | ﹤0.01% |
521
| – | – |
|
|
TC
2794
TuanChe
TC
$56.5M
| $37.7K | ﹤0.01% |
242
-24
| -9% | -$3.9K |
|
|
HLLY.WS
2795
DELISTED
Holley Inc Warrants
HLLY.WS
| $37.4K | ﹤0.01% |
59,100
| – | – |
|
2796
Hydrofarm Holdings
HYFM
$4.39M
| $37.2K | ﹤0.01% |
3,048
-13,934
| -82% | -$155K |
|
2797
InflaRx
IFRX
$302M
| $37K | ﹤0.01% |
+12,425
| New | +$47.3K |
|
2798
VirnetX Holding Corp
VHC
$52.1M
| $36.6K | ﹤0.01% |
7,207
-160
| -2% | -$1.24K |
|
2799
AquaBounty Technologies
AQB
$6.74M
| $36.2K | ﹤0.01% |
7,575
-1,748
| -19% | -$10.3K |
|
2800
CXApp
CXAI
$9.12M
| $35.5K | ﹤0.01% |
+392
| New | +$106K |
|
Similar funds
John Overdeck's Q3 2023 Portfolio in Review
As of Q3 2023, John Overdeck held 3,402 positions worth $37.2B, down 6.8% from $39.9B the previous quarter. Its ten largest holdings account for 7% of the portfolio.
John Overdeck withdrew a net $1.95B in Q3 2023, closing 472 positions and reducing 1,183 holdings. Its most notable exit was Etsy, an estimated $144M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Eli Lilly worth $232M.
- John Overdeck's largest Q3 2023 buy was Eli Lilly: 432,734 shares worth $232M.
- John Overdeck added most to Advanced Micro Devices in Q3 2023, an estimated $275M increase.
- John Overdeck's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $236M.
- John Overdeck fully exited Etsy in Q3 2023, selling an estimated $144M.
- John Overdeck's ten largest holdings make up 7% of its $37.2B portfolio in Q3 2023.
- John Overdeck opened 430 new positions and closed 472 in Q3 2023.
- John Overdeck's portfolio value fell 6.8% quarter-over-quarter to $37.2B.
Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.